Financial Management Professionals, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1568132
AUSTIN, TX
Position in REGN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$11,223
-$11,183 QoQ
Shares Held
18
-37.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#290
of 334 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Financial Management Professionals, Inc. holds $87,438 across 14 Biotechnology names. REGN ranks #3 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
80 | $39,738 | |
| 2 | ABVX |
Abivax S.A.
|
100 | $13,326 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
18 | $11,223 | |
| 4 | CDT |
CDT Equity Inc.
|
10,005 | $5,602 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
1,410 | $5,174 | |
| 6 | INCY |
Incyte Corp
|
36 | $4,080 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
35 | $2,002 | |
| 8 | CAI |
Caris Life Sciences, Inc.
|
96 | $1,710 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,223 | 18 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $22,406 | 29 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $15,437 | 20 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $11,245 | 20 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $10,500 | 20 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $21,563 | 34 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $24,931 | 35 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $37,844 | 36 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $37,837 | 36 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $113,573 | 118 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $108,029 | 123 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $102,870 | 125 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $84,069 | 117 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $95,313 | 116 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $22,366 | 31 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $21,354 | 31 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $8,275 | 14 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $9,777 | 14 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $8,209 | 13 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $7,867 | 13 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $7,261 | 13 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,365 | 5 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,898 | 6 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,679 | 3 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,870 | 3 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||